INFORMED.
LIVE

Entero Healthcare Solutions Limited

BSE: ENTERO544122ISIN INE010601016
  • Consumer Discretionary
  • Pharmacy Retail
  • BSE 1000

Share price

₹1,733.00+67.95 (+4.08%)
as of 18 Sep 2026
Entero Healthcare Solutions Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹1,149.40 to ₹1,733.00 (+50.8%). Low ₹949.80, high ₹1,891.50. Volume shown below the price.
52W high
₹1,919.25
52W low
₹944.00
Off 52W high
-9.70%
1M return
+24.83%
3M return
+58.72%
6M return
+54.67%
1Y return
+50.77%
20D avg volume
1,01,825
50 DMA
₹1,468.92
200 DMA
₹1,219.56

Key ratios Consolidated

Market cap
₹7,543 Cr
Current price
₹1,733.00
52W high / low
₹1,919.25 / ₹944.00
Face value
₹10.00
P/E
44.99
P/B
EPS (TTM)
₹38.52
Book value / share
ROE
ROCE
11.60%
Operating margin
Net margin
Debt / equity
0.32
Net debt
₹419.80 Cr
Interest cover
4.30
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
73.5 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
1,9401,9101,7071,5711,4041,339
3.014.014.614.795.837.29
1,8761,8561,6631,5311,3731,309
0.000.000.000.000.000.00
1,7251,6911,5261,3981,2991,205
69.4264.7663.9859.2157.5652.02
20.5717.3114.0112.4010.6610.49
12.3014.799.809.838.878.49
54.9556.6240.8439.5331.9429.84
67.1257.9548.5844.6236.3637.23
0.000.00-8.180.000.000.00
67.1257.9540.4044.6236.3637.23
15.0712.826.528.036.135.80
52.0545.1333.8836.6030.2331.42
8.776.446.357.266.395.91
Key metrics
99.9990.0564.2166.8555.8956.21
5.20%4.70%3.80%4.30%4.00%4.20%
2.70%2.40%2.00%2.30%2.20%2.30%
3.70%3.00%2.60%
38.20%42.60%
72.20%43.60%
MetricTTMFY26FY25FY24
Income statement
7,1286,5915,096
16.4219.2439.51
6,9266,4234,997
0.000.000.00
6,3415,9154,756
257.37245.50199.04
64.2954.3841.62
46.7243.2930.69
191.94168.93115.72
218.27187.51138.74
-8.18-8.180.00
210.09179.34138.74
42.4433.5031.30
167.66145.84107.43
28.8226.4421.80
Key metrics
321.10277.01211.05
4.50%4.20%4.10%
2.35%2.20%2.10%
11.60%9.70%
29.30%
35.80%
28.66-88.17
0.66-0.72
0.320.17
419.8069.53
73.578.3
Balance sheet
3,6002,703
2,5032,076
146.88229.28
1,212830.36
841.68659.78
126.5884.28
103.11132.06
725.33397.30
1,588845.02
566.68298.81
444.12298.81
122.560.00
1,7531,770
Cash flow
96.20-76.86
-303.06219.80
123.66-73.66
67.5411.31
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
83.2778.93106.7483.2279.3572.30
23.1439.9623.2524.2326.2925.87
101.81106.85124.1299.8496.4886.00
0.000.000.000.000.000.00
56.8149.5371.3361.3095.9167.18
12.2914.4315.1314.3313.9810.87
5.742.600.700.710.590.34
3.112.782.803.322.822.16
7.7512.197.4910.708.995.83
4.6112.045.877.619.1612.17
0.000.00-4.500.000.00-47.08
4.6112.041.377.619.16-34.91
1.15-1.380.571.912.21-7.84
3.4613.420.815.706.96-27.07
0.793.080.181.311.60-6.39
Key metrics
13.4617.424.8711.6412.57-32.41
16.20%22.10%4.60%14.00%15.80%-44.80%
4.20%17.00%0.80%6.80%8.80%-37.40%
0.80%0.50%-2.10%
4.90%9.20%
-50.30%149.60%
MetricTTMFY26FY25FY24
Income statement
352.16348.24408.67
110.58113.72114.37
432.62427.28449.18
0.000.000.00
238.97278.06423.39
56.1857.8747.35
9.754.611.52
12.0111.728.65
38.1339.3729.45
30.1334.6873.86
-4.50-4.50-47.08
25.6330.1926.78
2.253.317.60
23.3926.8819.18
5.366.184.41
Key metrics
47.3946.5236.95
13.46%13.40%9.00%
6.64%7.70%4.70%
1.90%1.70%
-14.80%
40.10%
-75.27-111.00
-2.22-5.68
0.060.00
50.92-151.18
106.9109.6
Balance sheet
2,1581,804
728.90809.46
56.76151.18
103.4799.86
73.33108.98
15.9119.01
17.9125.34
74.7986.05
321.87129.93
107.680.00
15.710.00
91.970.00
1,6831,650
Cash flow
-59.72-109.02
-132.28207.75
97.58-40.89
15.551.98

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
52.41%
QuarterJune 2026March 2026December 2025September 2025
Promoter %52.41%52.42%52.42%52.42%
HolderTypeHoldingPreviousChange
Orbimed Asia III Mauritius LimitedPromoter38.00%38.01%-0.01%
SURBHI SINGH(PRASID UNO FAMILY TRUST)Public10.45%10.46%-0.01%
Prabhat AgrawalPromoter9.26%9.26%0.00%
Prem SethiPromoter5.15%5.15%0.00%
Invesco India Aggressive Hybrid FundPublic4.31%4.35%-0.04%
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) FundPublic2.16%
Bank Of India Flexi Cap FundPublic2.12%
Cif Iii Scheme IPublic1.95%1.95%0.00%
Adya AgrawalPromoter Group0.00%0.00%0.00%
Vikas SethiPromoter Group0.00%0.00%0.00%
Komal GuptaPromoter Group0.00%0.00%0.00%
Uquifa Sciences UK LtdPromoter Group0.00%0.00%0.00%
Uquifa Sciences Mascarene Ltd MauritiusPromoter Group0.00%0.00%0.00%
Richa AgarwalPromoter Group0.00%0.00%0.00%
Vihaana SethiPromoter Group0.00%0.00%0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results